seed
Stage
About
Modulight Biotherapeutics is developing a precision neuromodulation platform using optogenetics to treat severe neurological disorders, initially targeting trigeminal neuropathic pain.
Explore Modulight Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.